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Microbial activityAbstract New derivatives of ﬁve member heterocyclic compounds containing oxazole and
benzothiazole rings are reported. These compounds have been characterized by elemental analysis,
FT-IR and 1H NMR spectroscopy. This study was designed to show the microbial activity differ-
ence for two types of ﬁve member heterocyclic rings. The compounds were screened for antibacte-
rial activity against Escherichia coli, Staphylococcus aureus and Pseudomonas aerugenosa in nutrient
agar medium, and for antifungal activity against Aspergillus niger and Candida albicans in Sabou-
raud,s dextrose agar medium. The results show that the derivatives containing benzothiazole moiety
are more active than the derivatives containing oxazole moiety.
ª 2012 Production and hosting by Elsevier B.V. on behalf of King Saud University.1. Introduction
Chemistry of heterocyclic compounds is one of the leading
lines of investigations in the organic chemistry. Heterocyclic
compounds are widely distributed in nature and are essential
for life. They play a vital role in the metabolism of all living
cells. There are vast numbers of pharmacologically active het-erocyclic compounds, many of which are a regular clinical use.
Nitrogen, sulphur and oxygen containing ﬁve member hetero-
cyclic compounds have occupied enormous signiﬁcance in the
ﬁeld of drug discovery process. We report herein the synthesis
and comparative the microbial activities for two types of ﬁve
member heterocyclic derivatives (oxazole and benzothiazole).
Oxazoles play a vital role in the manufacture of various bio-
logically active drugs as brain-derived neurotrophic factor
inducers (Maekawa et al., 2003), analgesic (Serrano et al.,
1995), trypanocidal activity (Pinto et al., 1997), antimitotic
agents with pro-apoptotic activity (Uckun, 2001), antifungal
activity (Kunes et al., 2001), anti-inﬂammatory (Kaspady
et al., 2009), antidepressant (Elmegeed et al., 2010), anticancer
(Liu et al., 2009), antimicrobial, antidiabetic and antiobesity.
(Mesaik et al., 2004; Khan et al., 2006).
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pounds with multiple applications and, although they have
been known from long ago to be biologically active (Kaur
et al., 2010; Prabhu et al., 2011; Yadav et al., 2011). It is bicy-
clic ring system with diverse chemical reactivity and broad
spectrum of biological activities such as antimicrobial,
antitumor, anti-inﬂammatory, antilieshmanial and antifungal
(Latrofa et al., 2005; Shi et al., 2001; Paramashivappa et al.,
2003; Delmas et al., 2004; Sonwane et al., 2008). They show,
for example, very intensive antitumor activity, especially the
phenyl-substituted benzothiazole (Bradshaw et al., 2002). 2-
substituted-6-nitro- and 6-aminobenzothiazole (Delmas et al.,
2002), ﬂuorobenzothiazoles (Pattan et al., 2002), and Schiff
bases derived from benzothiazoles (Mahmood-ul-Hasan
et al., 2002) show microbiological activity.
In continuation of the work on the synthesis of biologically
important heterocyclic compounds (Tomi et al., 2011; Tomi
et al., in press), herein is reported the synthesis and biological
activities of some oxazole and benzothiazole derivatives.
2. Experimental
All the chemicals used were procured from Sigma–Aldrich and
Fluka, and used without further puriﬁcation. Melting points
were determined in open capillary tubes on Electrothermal
capillary apparatus and are uncorrected, Elemental analysis
(C, H, and N) were carried out using a Perkin–Elmer model
2400 instrument, IR spectra were recorded on Fourier Trans-
form IR spectrophotometer (Shimadzu 8400S) using KBr disc
method. 1H NMR spectra were recorded in DMSO-d6 on Bru-
ker spectrometer model ultra shield at 300 MHz using TMS as
an internal reference standard.
2.1. 4-Methoxy-hippuric acid (1A)
Glysine (1.5 g, 0.02 mol) in 1N sodium hydroxide solution
(20 mL) was cooled at 0–5 C and the cold solution was added
dropwise to a solution of 4-methoxybenzoyl chloride (3.41 g,
0.02 mol) in chloroform (30 mL). The reaction mixture was
continued under stirring for an additional 1 h. The aqueous
layer was separated and acidiﬁed with 2N hydrochloric acid.
The product 1A was collected by ﬁltration and recrystallized
from ethanol as colorless needles. Yield (83%); mp: 178–
180 C; FT-IR (KBr disk, cm1) 3366 (N–H), 3190–2534
(O–H, carboxylic), 2933, 2847 (C–H aliph.) 1743 (C‚O, acid),
1625 (C‚O, amide); 1H NMR (DMSO-d6, 300 MHz, d) 8.65–
8.63 (t, 1H, NH), 7.86–7.79 (dd, 2H, Ar.H), 6.98–6.95 (dd, 2H,
Ar.H), 3.86–3.84 (d, 2H, CH2), 3.77 (s, 3H, OCH3). Anal.
Calcd. For C10H11NO4 (209.07 g/mol): C, 57.41; H, 5.30; N,
6.70. Found: C, 57.44; H, 5.26; N, 6.72.
2.2. 2-(4-Methoxyphenyl)-5-oxazolones (2A)
The hippuric acid (1A) was treated with equimolar quantity of
ethyl chloroformate in the presence of N-methylmorpholine in
methylene chloride at room temperature to afford the corre-
sponding azlactone (2A) as off white needles. Yield (80%);
mp: 86–88 C; FT-IR (KBr disk, cm1) 2944, 2843 (C–H
aliph.), 1785 (C‚O), 1633 (C‚N); 1H NMR (DMSO-d6,
300 MHz, d) 7.85–7.76 (dd, 2H, Ar.H), 7.07–7.01 (dd, 2H,
Ar.H), 4.36 (s, 2H, CH2), 3.87 (s, 3H, OCH3). Anal. Calcd.For C10H9NO3 (191.06 g/mol): C, 62.82; H, 4.74; N, 7.33.
Found: C, 62.76; H, 4.69; N, 7.36.
2.3. 2-Aza-1-(4-methoxyphenyl)-4-toluel-1,4-butanediones
(3A)
The azlactone (2A) (0.96 g, 0.005 mol) in (25 mL) of toluene in
excess was treated portionwise with (2.00 g, 0.015 mol) of
anhydrous aluminum chloride at room temperature. After
the addition, the reaction mixture was continued under stirring
for 24 h. The reaction mixture was then poured over crushed
ice with hydrochloric acid and the organic component was ex-
tracted with methylene chloride, washed with water and dried.
The solvent was removed to yield the crude azadiketones (3A),
which was crystallized from ethanol as deep gray powder.
Yield (71%); mp: >250 C; FT-IR (KBr disk, cm1) 3282
(N–H), 2956, 2841 (C–H aliph.), 1691 (C‚O ketone), 1634
(C‚O amide); 1H NMR (DMSO-d6, 300 MHz, d) 8.70–8.59
(t, 1H, NH), 7.93–7.91 (dd, 2H, Ar.H of phenyl attached
CH3), 7.74–7.72 (dd, 2H, Ar.H of phenyl attached OCH3),
7.36–7.34 (dd, 2H, Ar.H of phenyl attached CH3), 6.83–6.81
(dd, 2H, Ar.H of phenyl attached OCH3), 4.10–4.08 (d, 2H,
CH2), 3.93 (s, 3H, OCH3), 2.38 (s, 3H, CH3). Anal. Calcd.
For C17H17NO3 (283.12 g/mol): C, 72.07; H, 6.05; N, 4.94.
Found: C, 72.01; H, 6.10; N, 4.89.
2.4. 2-(4-Methylphenyl)-5-(4-methoxyphenyl)-1,3-oxazole
(4A)
The compound (3A) (2.83 g, 0.01 mol) was reﬂuxed with
(10 mL) phosphorus oxychloride for 48 h. and the reaction
mixture was then treated with ice water and the precipitate
was washed with 10% sodium bicarbonate solution and water,
dried and recrystalized in ethanol to afford the crude oxazole
(4A) in 77% yield, mp: 145–147 C; FT-IR (KBr disk, cm1)
2924, 2854 (C–H aliph.), 1641 (C‚N), 1244, 1078 (C–O–C);
1H NMR (DMSO-d6, 300 MHz, d) 8.07–8.05 (dd, 2H, Ar.H
of phenyl attached CH3), 7.73–7.71 (dd, 2H, Ar.H of phenyl at-
tached OCH3), 7.32–7.34 (dd, 2H, Ar.H of phenyl attached
CH3), 7.60 (s, 1H, –C‚H of oxazole moiety), 6.92–6.90 (dd,
2H, Ar.H of phenyl attached OCH3), 3.89 (s, 3H, OCH3),
2.34 (s, 3H, CH3). Anal. Calcd. For C17H15NO2 (265.11 g/
mol): C, 76.96; H, 5.70; N, 5.28. Found: C, 76.89; H, 5.65; N,
5.33.
2.5. 2-(4-Methylphenyl)-5-(4-hydroxyphenyl)-1,3-oxazole
(5A)
To Compound (4A) (0.63 g, 0.00238 mol) suspended in dry
benzene (25 mL), (1.00 g, 0.0075 mol) of anhydrous aluminum
chloride was added. The reaction mixture was reﬂuxed for
24 h. The solvent was evaporated and the residue was poured
into ice-water. The solid was collected and puriﬁed by dissolv-
ing in (30 mL) of 10% sodium hydroxide solution. The remin-
der solid was ﬁltered and the ﬁltrate was neutralized with 10%
hydrochloric acid. The crude product precipitate during the
neutralization washed with water several times and dried to
give the desired Compound (5A). Yield (71%); mp: >250 C
(decom.); FT-IR (KBr disk, cm1) 3479–3178 (broad O–H),
2922, 2852 (C–H aliph.), 1649 (C‚N), 1240, 1057 (C–O–C);
1H NMR (DMSO-d6, 300 MHz, d) 7.79–7.71 (dd, 2H, Ar.H
394 I.H.R. Tomi et al.of phenyl attached CH3), 7.31–7.26 (dd, 2H, Ar.H of phenyl
attached OH), 7.39–7.34 (dd, 2H, Ar.H of phenyl attached
CH3), 7.41 (s, 1H, –C‚H of oxazole moiety), 6.99–6.93 (dd,
2H, Ar.H of phenyl attached OH), 5.22 (s, 1H, OH), 2.36 (s,
3H, CH3). Anal. Calcd. For C16H13NO2 (251.09 g/mol): C,
76.48; H, 5.21; N, 5.57. Found: C, 76.59; H, 5.30; N, 5.66.
2.6. 2-(4-Methylphenyl)-5-(4-alkoxyphenyl)-1,3-oxazole
(6A)n
A mixture of compound (5A) (0.06 g, 0.00024 mol) and anhy-
drous potassium carbonate (0.033 g, 0.00024 mol) was dissolved
in acetone (10 mL). n-Alkyl bromide or iodide (0.0003 mol) was
added to this mixture dropwise and reﬂuxed for 24 h, then it was
added to ice-cold water. The crude solid product was washed
with 5% aqueous sodium bicarbonate solution and water sev-
eral times. The products obtained were dried and recrystallized
from ethanol. 1H NMR (DMSO-d6, 300 MHz, d) (6A)4, 7.99–
7.92 (dd, 2H, Ar.H of phenyl attached CH3), 7.71–7.67 (dd,
2H, Ar.H of phenyl attached OCH2), 7.29–7.24 (dd, 2H, Ar.H
of phenyl attachedCH3), 7.56 (s, 1H, –C‚Hof oxazolemoiety),
6.83–6.79 (dd, 2H, Ar.H of phenyl attached OCH2), 3.93 (s, 3H,
OCH2), 2.32 (s, 3H, CH3), 1.74–1.69 (m, 2H, CH2 attached
OCH2), 1.33–1.29 (m, 2H, CH2 attached CH3), 0.94–0.91 (t,
3H, CH3).
2.7. 2-(4-hydroxyphenylazo)-benzothiazole (1B)
2-Aminobenzothiazole (0.27 g, 0.00178 mol) was dissolved by
heating and stirring in (8 mL) of 85%phosphoric acid. The solu-
tion was cooled to 0 C in an ice bath, and then concentrated ni-
tric acid (4 mL) and a solution of sodium nitrite (0.13 g,
0.00187 mol) in (2 mL) of water was added. The mixture was
stirred vigorously and maintained at below 5 C during
10 min. Afterwards a solution of phenol (0.17 g, 0.00178 mol)
in (0.5 mL)water was added dropwise with stirring. Themixture
was poured into cold water (100 mL). The precipitate solid was
ﬁltered, washed several times with water and recrystallized from
ethanol. Yield (59%); mp: 269–272 C; FT-IR (KBr disk, cm1)
3410–3183 (broad O–H), 3064 (C‚H arom.), 1638 (C‚N),
1579 (N‚N), 636 (C–S–S); 1H NMR (DMSO-d6, 300 MHz,
d) 8.23–8.20 (d, 1H, (a) H of benzothiazole), 8.16–8.11 (d, 1H,
(d)H of benzothiazole), 7.57–7.49 (t, 2H, (b) and (c) H of benzo-
thiazole), 7.17–7.12 (dd, 2H, Ar.H of phenyl attached OH),
6.77–6.71 (dd, 2H, Ar.H of phenyl attached OH), 5.12 (s, broad,
1H, OH). Anal. Calcd. For C13H9N3OS (255.05 g/mol): C,
61.16; H, 3.55; N, 16.46. Found: C, 61.22; H, 3.61; N, 16.51.
2.8. 2-(4-Aceticphenylazo)-benzothiazole (2B)
Amixture of compound (1B) (0.40 g, 0.0016 mol), 1-chloro ace-
tic acid (0.15 g, 0.0016 mol) and anhydrous potassium carbon-
ate (0.24 g, 0.0017 mol) was dissolved in acetone (25 mL). The
mixture was reﬂuxed for 24 h, and then it was added to ice-cold
water. The crude oily product was dissolved in di ethyl ether and
washed with 5% aqueous sodium bicarbonate solution and
water several times. The product was dried over MgSO4 and it
was obtained after evaporated the solvent. Yield (45%); FT-
IR (ﬁlm, cm1) 3171–2666 (broad carboxylic O–H), 3071
(C‚H arom.), 1724 (C‚O carboxylic), 1629 (C‚N), 1580
(N‚N), 644 (C–S–S); 1H NMR (DMSO-d6, 300 MHz, d)11.09 (s, 1H, OH carboxylic), 8.26–8.22 (d, 1H, (a) H of benzo-
thiazole), 8.11–8.08 (d, 1H, (d)Hof benzothiazole), 7.61–7.55 (t,
2H, (b) and (c) H of benzothiazole), 7.21–7.16 (dd, 2H, Ar.H of
phenyl attachedOCH2COOH), 6.82–6.76 (dd, 2H,Ar.H of phe-
nyl attached OCH2COOH), 4.81 (s, 2H, CH2). Anal. Calcd. For
C15H11N3O3S (313.05 g/mol): C, 57.50; H, 3.54; N, 13.41.
Found: C, 57.59; H, 3.61; N, 13.51.
2.9. 2-(4-Acetylchloridephenylazo)-benzothiazole (3B)
Compound (2B) (0.31 g, 0.001 mol) was reﬂuxed with thionyl
chloride (5 mL) in presence of 1 drop of DMF. Unreacted thio-
nyl chloride was removed under reduced pressure to obtained
oily acid chloride (3B). This compound is very active and sensi-
tive to themoisture, for this reason is not possible to obtain their
physical properties and spectral analysis and used without
puriﬁcation.
2.10. 2-[4-(4-Substitutedacetylbenzoyloxy)-phenylazo]-
benzothiazole (4Bx,y,z)
To a stirred solution of various phenols (0.001 mol) in (5 mL) of
dried pyridine, the compound (3B) in (5 mL) of dried pyridine
was added dropwise at 0 C. After the addition had been com-
pleted, the resulting mixture was stirred overnight at room tem-
perature then poured into (50 mL) of 10% HCl solution. The
precipitate was ﬁltered, washed with solution of 10% NaHCO3
and then with water several times, dried and recrystallized from
ethanol. 1H NMR (DMSO-d6, 300 MHz, d) (4B)z 8.28–8.24 (d,
1H, (a)H of benzothiazole), 8.09–8.06 (d, 1H, (d)H of benzothi-
azole), 7.52–7.48 (t, 2H, (b) and (c) H of benzothiazole), 6.99–
6.95 (dd, 2H, Ar.H of phenyl attached OCH3), 6.73–6.69 (dd,
2H, Ar.H of phenyl attached OCH3), 7.19–7.14 (dd, 2H, Ar.H
of phenyl attached OCH2), 6.79–6.73 (dd, 2H, Ar.H of phenyl
attached OCH2), 4.89 (s, 2H, CH2), 3.77 (s, 3H, OCH3).3. Results and discussion
3.1. Synthesis
The key intermediates involved in the synthesis of desired oxaz-
oles (6A)n are described in Scheme 1.
All the newly synthesized compounds gave satisfactory anal-
ysis for the proposed structures, which were conﬁrmed on the
basis of their elemental analysis and spectral (FT-IR and 1H
NMR) data. The characterization data of all compounds are gi-
ven in the experimental section.
The compound 1A was synthesized by the reaction of 4-
methoxybenzoyl chloride with glycine according to Steiger,s
procedure (Steiger, 1944; Schiketanz et al., 2002) to afford the
corresponding hippuric acid 1A. The FT-IR spectrum of this
product indicated the absence of absorption bands due to
NH2 group of glycine and the presence of a N–H and C‚O
absorption bands at 3366 and 1625 cm1 respectively. Also
the 1H NMR spectrum of this compound showed a triplet at
d8.65–8.63 ppm integrating for proton of the NH and a doublet
at d 3.86–3.84 ppm integrating for protons of the CH2 group.
The compound 1A was dehydrated to the respective azlazctone
2A. The disappearance of triplet peak in 1HNMR spectrum at d
8.65–8.63 ppm in compound 1A, assigned to the N–H group
1A
H3CO
O
C
N
O
H3CO C
O
H
N
H2
C C
O
OH
2A
H3C
O
N
OH
5A
H3C
O
N
OCnH2n+1
H2N
H2
C C
O
OH
H3C C
O
H2
C
H
N C
O
OCH3
3A
4A
H3C
O
N
OCH3
H3CO C
O
Cl +
a
b
c
d
e
f
6An
n = 4, 6, 8
Scheme 1 Synthetic route of compounds (6A)n, reactions and reagents: (a) 1 N NaOH, chloroform; (b) ethy chloroformate, N-methyl
morpholine, methylene chloride; (c) AlCl3, toluene; (d) POCl3; (e) AlCl3, benzene; (f) K2CO3,acetone, n-alkyl bromide or iodide.
Synthesis, characterization and comparative study the microbial activity of some heterocyclic compounds 395and appearance a strong band in FT-IR spectrum at 1785 cm1
of the carbonyl group in azlactones in compound 2A are good
evidence for the structure given to the product. The azlactone
2A was then reacted with toluene under Friedel–Crafts reaction
conditions using anhydrous aluminum chloride in the presence
of excess reactant as a solvent. The FT-IR spectrum of this com-
pound 3A showed two sharp absorption bands, the ﬁrst appears
at 1691 cm1 and is attributed to carbonyl function of the ke-
tone and the other, observed at 1634 cm1, was assigned to a
carbonyl stretching frequency corresponding to the amide car-
bonyl. Also the 1H NMR spectrum of this compound showed
the peaks at d 8.70–8.59, 4.10–4.08, and 2.38 ppm. These peaksPOCl3
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N
H
C
C CH3
H
H3CO C
O
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Scheme 2 The mechanism steps oin 1H NMR spectrum and two carbonyl bands in FT-IR spec-
trum of compound 3A were utilized to conﬁrm the structure
of this compound. After workup, the intermediate 3A was then
dehydrated in the presence of phosphorous oxychloride to af-
ford the corresponding oxazole 4A. The mechanism of dehydra-
tion (Padmavathi et al., 2008) in presence of POCl3 is depicted
in the following steps: (Scheme 2).
The disappearance of two carbonyl bands inFT-IR spectrum
and appearance the singlet peak at d 7.60 ppm in 1HNMR spec-
trum that is assigned to the C‚Hof oxazole ring for compound
4A are the good prove to obtained this compound. The com-
pound 4Awas demethylatedwith anhydrous aluminum chlorideH3CO C
N CH
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Scheme 3 Synthetic route of compounds (4B)x,y,z, reactions and reagents: (a) H3PO4, HNO3, NaNO2; (b) K2CO3, acetone, 1-chloro
acetic acid; (c) thionyl chloride, DMF; (d) pyridine, various phenols.
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hydroxyphenyl)-1,3-oxazole (5A). The 1H NMR spectrum of
compound 5A showed the hydroxyl group at d 5.22 ppm. The
compounds 6A4, 6A6 and 6A8 were synthesized by alkylation
reaction of compound 5A with n-bromo- or iodoalkane in dry
acetonewith presence of anhydrous potassium carbonate. Table
1 shows the physical properties, elemental analysis and FT-IR
spectral data of these compounds. The disappearance of peak
at d 5.22 ppm in compound 5A, assigned to the hydroxyl group
and appearance the peaks of alkyl groups (OCH2, CH2 and
CH3) in compound 6A4 are good evidence for the structure given
to the product.
The designated of benzothiazole derivatives were synthe-
sized according to Scheme 3.
The azo compound 1B was prepared by coupling between
diazonium salt of the 2-aminobenzothiazole with phenol.Table 1 The physical properties, elemental analysis and FT-IR spe
Compound Molar mass g/mol M.P. (C) Yield (%) Analysis C, H and
C H
6A4 307.16 139–140 74 78.15 6.8
(78.24) (6.
6A7 335.19 129–131 77 78.77 7.5
(78.69) (7.
6A8 363.22 123–125 81 79.30 8.0
(79.39) (7.
Table 2 The physical properties, elemental analysis and FT-IR spe
Compound Molar mass
g/mol
M.P. (C) Yield (%) Analysis C, H and
C H
4Bx, G = CN 414.08 168–169 65 63.76 3.40
(63.81) (3.46
4By, G = NO2 434.07 181–184 51 58.06 3.25
(58.11) (3.31
4Bz, G = OCH3 419.09 219–221 74 63.00 4.09
(62.97) (4.15The FT-IR spectrum of this compound showed absorption
broad peak at 3410–3183 cm1 due to the intermolecularly
hydrogen bonded of hydroxyl group. The compound 2B was
synthesized by alkylation reaction of compound 1B with 1-
chloro acetic acid in dry acetone with presence of anhydrous
potassium carbonate.
The sharp peak at 1724 cm1 in FT-IR spectrum and sin-
glet peak at d 11.09 ppm in 1H NMR spectrum of compound
2B are the good prove to formation the acid compound, this
compound was treated with thionyl chloride in presence of
DMF to afforded the corresponding acid chloride 3B, this
compound is very sensitive to the moisture, for this cause is
not possible to obtain their FT-IR and 1H NMR spectra. Fi-
nally, this compound 3B was condensed with one equivalent
of various phenols in dry pyridine as solvent and acid acceptor
to yield new compounds 4Bx,y,z. The physical properties, ele-ctral data of compounds 6An.
N (%) found/(calcd.) FT-IR characteristic bands (t cm1)
N C–H aliph. C‚N C–O–C sym. and asym.
9 4.56 2926 1642 1251, 1035
94) (4.62) 2854
1 4.18 2928 1635 1253, 1031
43) (4.23) 2853
4 3.85 2924 1639 1257, 1039
98) (3.93) 2847
ctral data of compounds 4Bx,y,z.
N (%) found/(calcd.) FT-IR characteristic bands (t cm1)
N C–H arom. C‚O Characteristic of G group
13.52 3066 1714 2228
) (13.44)
12.90 3061 1719 1491, 1351
) (12.84)
10.02 3059 1720 2933, 2861
) (10.10)
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Synthesis, characterization and comparative study the microbial activity of some heterocyclic compounds 397mental analysis and FT-IR spectral data of all compounds
(4B) are summarized in Table 2. In the FT-IR spectra of these
esters, a band near 1714 cm1 was shown that is assigned the
carbonyl of these esters. The 1H NMR spectrum of com-
pound 4Bz for example of esters compounds showed the peak
at d 3.77 ppm for the hydrogen of lateral methoxy group, are
good evidence for the structure given to the product.
3.2. Biological evaluation
All the compounds have been screened for both antibacterial
and antifungal activities using cup-plate agar diffusion meth-
od (Barry, 1976) by measuring the inhibition zone in mm.
Oﬂoxacin (50 lg/mL) was used as standard drug for antibac-
terial activity, and ketoconazole (50 lg/mL) as a standard
drug for antifungal activity. The compounds were screened
for antibacterial activity against Escherichia coli, Staphylococ-
cus aureus and Pseudomonas aerugenosa in nutrient agar med-
ium, and for antifungal activity against Aspergillus niger and
Candida albicans in Sabouraud,s dextrose agar medium. These
sterilized agar media were poured into Petri-dishes and al-
lowed to solidify. On the surface of the media microbial sus-
pensions were spread with help of sterilized triangular loop.
A stainless steel cylinder of 8 mm diameter (pre-sterilized)
was used to bore cavities. All the synthesized compounds
(50 lg/mL) were placed serially in the cavities with the help
of micropipette and allowed to diffusion for 1 h, DMSO was
used as solvent for all compounds, and as control. These plates
were incubated at 37 C for 24 h and 28 C for 48 h, for anti-
bacterial and antifungal activities respectively. The zone of
inhibition observed around the cups after respective incuba-
tion was measured and percent inhibition of the compounds
was calculated. The results are summarized in Table 3.
The benzothiazole derivatives 4Bx,y,z showed good anti-
bacterial activity against E. coli, S. aureus and P. aerugenosa
when compared with the oxazole derivatives 6An. The com-
pounds 4By and 4Bz showed potent activity against E. coli
and P. aerugenosa respectively, when compared with standard
drug. Rest of the compounds showed moderate to good anti-
bacterial activity. The oxazole derivatives 6An were also
found to be effective against microorganisms at the same con-
centration. The compound 6A8 showed maximum antibacte-
rial activity against P. aerugenosa, whereas compounds 6A4
and 6A8 showed the same inhibition against E. coli.
The pattern of result of the antifungal activity of the test
compounds was the same from their antibacterial activity.
Rest of the benzothiazole derivatives showed moderate to
good antifungal activity, whereas the oxazole derivatives
showed moderate to low antifungal activity against both A.
niger and C. albicans. Thus, it is concluded from the screening
results that benzothiazole derivatives were most effective
against all microorganisms at a concentration of 50 lg/mL
(Gajdos et al., 2009).Acknowledgements
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